Maxcyte (MXCT) Cash from Financing Activities (2020 - 2026)
Maxcyte (MXCT) reported Cash from Financing Activities of $5000.0 for Q1 2026, down 98.69% year-over-year from $383000.0 in Q1 2025, and down 95.24% on a QoQ basis from $105000.0 in Q4 2025.
Maxcyte (MXCT) has 7 years of Cash from Financing Activities data on file, last reported at $5000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 98.69% year-over-year to $5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $278000.0 (down 83.99% YoY) and the FY2025 annual result came in at $656000.0, down 68.09% from the prior year.
- Cash from Financing Activities retreated to $5000.0 in Q1 2026 per MXCT's latest filing, from $105000.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.5 million in Q1 2023 and bottomed at $5000.0 in Q1 2026.
- The 5-year median for Cash from Financing Activities is $383000.0 (2025), against an average of $455764.7.
- Peak annual rise in Cash from Financing Activities reached 1087.96% in 2022, while the deepest fall reached 99.76% in 2022.
- Tracing MXCT's Cash from Financing Activities over 5 years: stood at $1.2 million in 2022, then sank by 59.77% to $493000.0 in 2023, then decreased by 16.43% to $412000.0 in 2024, then plunged by 74.51% to $105000.0 in 2025, then tumbled by 95.24% to $5000.0 in 2026.
- Per Business Quant, the three latest MXCT Cash from Financing Activities figures stand at $5000.0 (Q1 2026), $105000.0 (Q4 2025), and $14000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn | 5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Mar 31, 2025 | 383,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Dec 31, 2024 | 412,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Sep 30, 2024 | 228,000.00 |
| Jun 30, 2024 | 713,000.00 |
| Jun 30, 2024 | 713,000.00 |
| Mar 31, 2024 | 703,000.00 |
| Mar 31, 2024 | 703,000.00 |
| Dec 31, 2023 | 493,000.00 |
| Dec 31, 2023 | 493,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Jun 30, 2023 | 157,000.00 |
| Mar 31, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.46 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 444,400.00 |
| Sep 30, 2022 | 444,400.00 |
| Jun 30, 2022 | 325,500.00 |
| Jun 30, 2022 | 325,500.00 |
| Mar 31, 2022 | 892,600.00 |
| Mar 31, 2022 | 892,600.00 |
| Dec 31, 2021 | 1.21 Mn |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 184.59 Mn |
| Sep 30, 2021 | 184.59 Mn |
| Jun 30, 2021 | 27,400.00 |
| Jun 30, 2021 | 27,400.00 |
| Mar 31, 2021 | 48.90 Mn |
| Mar 31, 2021 | 48.90 Mn |
| Dec 31, 2020 | 90,900.00 |
| Dec 31, 2020 | 90,900.00 |
| Sep 30, 2020 | 262,100.00 |
| Sep 30, 2020 | 262,100.00 |